The Mexican laboratory for biological agents and reagents Birmex, which plans to bottle and package the Russian Sputnik V coronavirus vaccine, has estimated its potential production at 90 million doses of vaccine per year. “The country will begin mass packaging of the Sputnik V vaccine, which, according to our estimates, will produce about 90 million […]
Mexico spoke about prospects for the production of “Sputnik V”
The Mexican laboratory for biological agents and reagents Birmex, which plans to bottle and package the Russian Sputnik V coronavirus vaccine, has estimated its potential production at 90 million doses of vaccine per year.
“The country will begin mass packaging of the Sputnik V vaccine, which, according to our estimates, will produce about 90 million doses per year”, – the laboratory’s website said.
The company is currently preparing and installing a new production line at the facilities of the National Institute of Virology and the National Institute of Hygiene of Mexico. With the commissioning of this line, Birmex expects to cover the domestic market demand for vaccine packaging and enter the international market as their supplier.
The immunization program for the Mexican population began at the end of December with the staff of coronavirus hospitals. For these purposes, the authorities use five different vaccines, which are purchased abroad or produced locally, receiving the active ingredient from biolaboratories – Pfizer / BioNTech, Oxford / AstraZeneca, Sinovac, Cansino and Sputnik V.
According to the latest information from the Ministry of Health, over 22 million doses of COVID-19 vaccines have been delivered to Mexico, of which 17 million have already been distributed to citizens. More than 6 million people are fully vaccinated.
Mexico spoke about prospects for the production of “Sputnik V”
